Mariko DeWire

1.3k total citations
23 papers, 416 citations indexed

About

Mariko DeWire is a scholar working on Genetics, Molecular Biology and Neurology. According to data from OpenAlex, Mariko DeWire has authored 23 papers receiving a total of 416 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Genetics, 10 papers in Molecular Biology and 7 papers in Neurology. Recurrent topics in Mariko DeWire's work include Glioma Diagnosis and Treatment (16 papers), Neuroblastoma Research and Treatments (7 papers) and Advanced Breast Cancer Therapies (2 papers). Mariko DeWire is often cited by papers focused on Glioma Diagnosis and Treatment (16 papers), Neuroblastoma Research and Treatments (7 papers) and Advanced Breast Cancer Therapies (2 papers). Mariko DeWire collaborates with scholars based in United States, United Kingdom and Australia. Mariko DeWire's co-authors include Maryam Fouladi, Rachid Drissi, Amar Gajjar, Charles B. Stevenson, Shiva Senthil Kumar, Stewart Goldman, Lili Miles, Christine Fuller, Frederick A. Boop and Alberto Broniscer and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and Annals of Oncology.

In The Last Decade

Mariko DeWire

21 papers receiving 409 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mariko DeWire United States	14	266	194	125	90	60	23	416
Akiyoshi Ogino Japan	15	215 0.8×	199 1.0×	90 0.7×	66 0.7×	99 1.6×	33	533
Christine Lu‐Emerson United States	8	234 0.9×	169 0.9×	118 0.9×	99 1.1×	126 2.1×	19	551
Wafik Zaky United States	12	271 1.0×	200 1.0×	110 0.9×	92 1.0×	59 1.0×	66	461
Michal Zápotocký Czechia	12	397 1.5×	168 0.9×	199 1.6×	104 1.2×	45 0.8×	47	508
Jennifer Hammes Germany	9	280 1.1×	268 1.4×	118 0.9×	68 0.8×	25 0.4×	12	457
Jennifer Elster United States	8	133 0.5×	150 0.8×	103 0.8×	51 0.6×	60 1.0×	26	325
Sarah Fattet France	9	148 0.6×	263 1.4×	56 0.4×	41 0.5×	88 1.5×	14	412
Kee Kiat Yeo United States	10	193 0.7×	90 0.5×	156 1.2×	53 0.6×	60 1.0×	36	325
Guillaume Bergthold United States	9	319 1.2×	123 0.6×	224 1.8×	119 1.3×	54 0.9×	17	440
Jacquelyn J. Roth United States	13	140 0.5×	229 1.2×	49 0.4×	57 0.6×	53 0.9×	25	473

Countries citing papers authored by Mariko DeWire

Since Specialization

Citations

This map shows the geographic impact of Mariko DeWire's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mariko DeWire with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mariko DeWire more than expected).

Fields of papers citing papers by Mariko DeWire

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mariko DeWire. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mariko DeWire. The network helps show where Mariko DeWire may publish in the future.

Co-authorship network of co-authors of Mariko DeWire

This figure shows the co-authorship network connecting the top 25 collaborators of Mariko DeWire. A scholar is included among the top collaborators of Mariko DeWire based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mariko DeWire. Mariko DeWire is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhu, Xiaoting, Margot Lazow, Shiva Senthil Kumar, et al.. (2021). A pilot radiogenomic study of DIPG reveals distinct subgroups with unique clinical trajectories and therapeutic targets. Acta Neuropathologica Communications. 9(1). 14–14. 15 indexed citations

Kumar, Shiva Senthil, Xiaoting Zhu, Deepak Kumar Mishra, et al.. (2020). Diffuse Intrinsic Pontine Glioma Cells Are Vulnerable to Mitotic Abnormalities Associated with BMI-1 Modulation. Molecular Cancer Research. 18(11). 1711–1723. 14 indexed citations

DeWire, Mariko, James Leach, Christine Fuller, et al.. (2020). EPCT-19. A PHASE I STUDY OF RIBOCICLIB AND EVEROLIMUS FOLLOWING RADIATION THERAPY IN CHILDREN WITH NEWLY DIAGNOSED NON-BIOPSIED DIFFUSE PONTINE GLIOMAS (DIPG) AND RB+ BIOPSIED DIPG AND HIGH GRADE GLIOMAS (HGG). Neuro-Oncology. 22(Supplement_3). iii307–iii307. 1 indexed citations

Abdelbaki, Mohamed S, Bhuvana A. Setty, Mariko DeWire, Timothy P. Cripe, & Richard Curry. (2020). A pediatric and young adult phase I dose escalation study of BXQ-350 for solid and central nervous system tumors.. Journal of Clinical Oncology. 38(15_suppl). 2541–2541. 2 indexed citations

Fuller, Christine, Daniel R. Boué, Diana S. Osorio, et al.. (2018). LGG-24. TEMPORAL GENOMIC HETEROGENEITY IN PEDIATRIC LOW-GRADE GLIOMAS. Neuro-Oncology. 20(suppl_2). i109–i109. 1 indexed citations

DeWire, Mariko, Christine Fuller, Trent R. Hummel, et al.. (2018). DIPG-73. CLEE011XUS17T (NCT 02607124): A PHASE I/II STUDY OF RIBOCICLIB (LEE011) FOLLOWING RADIATION THERAPY (RT) IN CHILDREN AND YOUNG ADULTS WITH NEWLY DIAGNOSED NON-BIOPSIED DIFFUSE PONTINE GLIOMAS (DIPG) AND RB+ BIOPSIED DIPG AND HIGH GRADE GLIOMAS (HGG). Neuro-Oncology. 20(suppl_2). i64–i64.

Takiar, Vinita, et al.. (2016). Radiation and subsequent reirradiation outcomes in the treatment of diffuse intrinsic pontine glioma and a systematic review of the reirradiation literature. Practical Radiation Oncology. 7(2). 86–92. 33 indexed citations

Anderson, Jane L., Ranjithmenon Muraleedharan, Ronald R. Waclaw, et al.. (2016). The transcription factor Olig2 is important for the biology of diffuse intrinsic pontine gliomas. Neuro-Oncology. 19(8). 1068–1078. 26 indexed citations

DeWire, Mariko, Trent R. Hummel, Lionel M.L. Chow, et al.. (2016). TB-25LIMITED AUTOPSY IN PEDIATRIC BRAIN TUMOR PATIENTS WITH A COMPREHENSIVE MULTI-DISCIPLINARY APPROACH RESULTS IN PARENTAL SATISFACTION AND SCIENTIFIC INNOVATION. Neuro-Oncology. 18(suppl 3). iii173.1–iii173. 1 indexed citations

10.

DeWire, Mariko, Maryam Fouladi, David C. Turner, et al.. (2015). An open-label, two-stage, phase II study of bevacizumab and lapatinib in children with recurrent or refractory ependymoma: a collaborative ependymoma research network study (CERN). Journal of Neuro-Oncology. 123(1). 85–91. 43 indexed citations

11.

Hummel, Trent R., Ralph Salloum, Rachid Drissi, et al.. (2015). A pilot study of bevacizumab-based therapy in patients with newly diagnosed high-grade gliomas and diffuse intrinsic pontine gliomas. Journal of Neuro-Oncology. 127(1). 53–61. 38 indexed citations

12.

Gass, David, Mariko DeWire, Lionel M.L. Chow, et al.. (2015). Pediatric tectal plate gliomas: a review of clinical outcomes, endocrinopathies, and neuropsychological sequelae. Journal of Neuro-Oncology. 122(1). 169–177. 12 indexed citations

13.

Dorris, Kathleen, Matthew Sobo, Arzu Onar‐Thomas, et al.. (2014). Prognostic significance of telomere maintenance mechanisms in pediatric high-grade gliomas. Journal of Neuro-Oncology. 117(1). 67–76. 32 indexed citations

14.

Salloum, Ralph, Mariko DeWire, Adam Lane, et al.. (2014). Patterns of progression in pediatric patients with high-grade glioma or diffuse intrinsic pontine glioma treated with Bevacizumab-based therapy at diagnosis. Journal of Neuro-Oncology. 121(3). 591–598. 14 indexed citations

15.

Geoerger, Birgit, Franck Bourdeaut, Steven G. DuBois, et al.. (2014). Phase I Study of Lee011 (Cdk4/6 Inhibitor) in Patients with Malignant Rhabdoid Tumors, Neuroblastoma, and Cyclin D–Cdk4/6 Pathway-Activated Tumors. Annals of Oncology. 25. iv151–iv151. 8 indexed citations

16.

Bid, Hemant K., Doris A. Phelps, Linlin Xiao, et al.. (2013). Development, Characterization, and Reversal of Acquired Resistance to the MEK1 Inhibitor Selumetinib (AZD6244) in an In Vivo Model of Childhood Astrocytoma. Clinical Cancer Research. 19(24). 6716–6729. 49 indexed citations

17.

DeWire, Mariko, Chris Beltran, Frederick A. Boop, et al.. (2012). Radiation Therapy and Adjuvant Chemotherapy in a Patient With a Malignant Glioneuronal Tumor and Underlying Ataxia Telangiectasia: A Case Report and Review of the Literature. Journal of Clinical Oncology. 31(1). e12–e14. 14 indexed citations

18.

Klimo, Paul, Mariko DeWire, Robert A. Sanford, et al.. (2011). Resection of infantile brain tumors after neoadjuvant chemotherapy: the St. Jude experience. Journal of Neurosurgery Pediatrics. 8(3). 251–256. 36 indexed citations

19.

DeWire, Mariko, David W. Ellison, Zoltán Patay, et al.. (2009). Fanconi anemia and biallelic BRCA2 mutation diagnosed in a young child with an embryonal CNS tumor. Pediatric Blood & Cancer. 53(6). 1140–1142. 18 indexed citations

20.

DeWire, Mariko, et al.. (2005). The "black box" controversy.. PubMed. 98(1). 41–2.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact